Form 4: Intuitive Surgical Executive Myriam Curet Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Summary
- Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc., executed a transaction involving the company's common stock on July 23, 2024.
- Curet exercised non-qualified stock options to acquire 2,818 shares of common stock at a price of $177.9867 per share.
- Simultaneously, Curet sold 2,818 shares of common stock at a price of $458.13 per share.
- These transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on August 12, 2024.
- Following these transactions, Curet directly owns 298 shares of common stock and 2,257 non-qualified stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the executive's confidence in the company.
Future Outlook
The executive's transactions are governed by a pre-arranged trading plan, suggesting a pre-determined strategy for stock sales.
Industry Context
Executive stock transactions are common and closely monitored, especially in high-growth technology companies like Intuitive Surgical. The use of 10b5-1 plans is a standard practice to avoid insider trading accusations.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry often include stock options and restricted stock units to align management's interests with those of shareholders.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.
- The vesting schedules and exercise prices of these options are typically benchmarked against industry peers to ensure competitiveness and retention.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
- The use of a 10b5-1 plan ensures transparency and reduces concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 02/28/2030 | Expiration date of Non-Qualified Stock Option |
| 07/23/2024 | Date of stock option exercise and share sale |
| 07/24/2024 | Date of Form 4 filing |
| 08/12/2024 | Expiration date of the 10b5-1 trading plan |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.